Announced Wed, 1 Oct · 20:28 IST
Dear Sir/Madam, Please find the attached intimation under Regulation 57(5) of SEBI (LODR) Regulations, 2015. Thanking You.
Compliance View source PDF
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve
Awaiting price reaction for this filing.
AI summary
Prism Medico and Pharmacy Ltd has submitted a regulatory compliance filing to BSE and MSE for the quarter ending 30 September 2025. Under SEBI's Regulation 57(5), the company confirmed it has not issued any non-convertible securities. As a result, there were no interest, dividend, or principal payment obligations due during the quarter from 1 July 2025 to 30 September 2025.
Likely market impact
This is a routine nil compliance filing with no material impact on shareholders or the stock price. It simply confirms the absence of any non-convertible securities and related payment dues for the quarter.